ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

JAGX Jaguar Health Inc

0.087
0.0141 (19.34%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 61,877,221
Bid Price 0.0856
Ask Price 0.087
News -
Day High 0.0875

Low
0.0512

52 Week Range

High
1.22

Day Low 0.0713
Company Name Stock Ticker Symbol Market Type
Jaguar Health Inc JAGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0141 19.34% 0.087 19:59:43
Open Price Low Price High Price Close Price Prev Close
0.0725 0.0713 0.0875 0.0899 0.0729
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
26,279 61,877,221 $ 0.077954 $ 4,823,577 - 0.0512 - 1.22
Last Trade Time Type Quantity Stock Price Currency
19:59:48 1 $ 0.0856 USD

Jaguar Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.57M 50.76M - 11.96M -47.45M -0.94 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Jaguar Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No JAGX Message Board. Create One! See More Posts on JAGX Message Board See More Message Board Posts

Historical JAGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.08410.08980.06530.074124350,501,0470.00293.45%
1 Month0.05910.16280.0580.098934378,611,9740.027947.21%
3 Months0.14060.16280.05120.096393839,162,792-0.0536-38.12%
6 Months0.2650.5290.05120.129642521,499,019-0.178-67.17%
1 Year1.001.220.05120.176012211,565,666-0.913-91.30%
3 Years135.75228.000.051231.607,074,726-135.66-99.94%
5 Years1,640.6251,916.250.0512109.288,485,685-1,640.54-99.99%

Jaguar Health Description

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.

Your Recent History

Delayed Upgrade Clock